Ongoing Phase III Randomized Trial of Salvage DFP-10917 Vs. Non-Intensive Reinduction or Intensive Reinduction for Acute Myelogenous Leukemia (AML)-MedSci.cn

Ongoing Phase III Randomized Trial of Salvage DFP-10917 Vs. Non-Intensive Reinduction or Intensive Reinduction for Acute Myelogenous Leukemia (AML)

Pardee, T; Keng, M; Eshima, K; Iizuka, K; Zhang, C

BLOOD, 2023; 142 ():

科室
- - 订阅+
  - 更多科室
工具
服务